Recent Press Releases Dec 18, 2024 RECOVER Clinical Study Shows Meaningful Benefits of LivaNova’s VNS Therapy System in Select Secondary Endpoints for Unipolar Patients with Treatment-Resistant Depression Dec 05, 2024 LivaNova to Present Scientific Data at American Epilepsy Society 2024 Annual Meeting Nov 14, 2024 LivaNova to Present at the Stifel, Wolfe, and Piper Sandler Healthcare Conferences Nov 11, 2024 LivaNova Announces OSPREY Clinical Study Meets Primary Safety and Efficacy Endpoints View All News Releases View All News Upcoming Events More events are coming soon. View All Events View All Events
